首页> 外文期刊>Frontiers in Cell and Developmental Biology >Characterization of Dysregulated lncRNA-Associated ceRNA Network Reveals Novel lncRNAs With ceRNA Activity as Epigenetic Diagnostic Biomarkers for Osteoporosis Risk
【24h】

Characterization of Dysregulated lncRNA-Associated ceRNA Network Reveals Novel lncRNAs With ceRNA Activity as Epigenetic Diagnostic Biomarkers for Osteoporosis Risk

机译:失调的LNCRNA相关的Cerna网络的表征揭示了Cerna活性的新型LNCRNA作为表观遗传诊断生物标志物,用于骨质疏松症风险

获取原文
           

摘要

The altered expression of long non-coding RNAs (lncRNAs) has been implicated in the development and human diseases. However, functional roles and regulatory mechanisms of lncRNA as competing endogenous RNAs (ceRNAs) in osteoporosis, and their potential clinical implication for osteoporosis risk are largely unexplored. In this study, we performed integrated analysis for paired expression profiles and regulatory relationships of dysregulated lncRNAs, mRNAs and miRNAs based on “ceRNA hypothesis”, and constructed an osteoporosis-related dysregulated miRNA-mediated lncRNA-mRNA ceRNA network (DysCeNet) composing of 105 nodes (including 8 miRNAs, 24 mRNAs, and 73 lncRNAs) and 515 edges. Functional analysis suggested that the DysCeNet was involved in known osteoporosis or bone metabolism-related biological progression and pathways. Then we performed random forest-based feature selection for 73 lncRNAs with ceRNA activity and identified 25 of 73 lncRNAs with ceRNA activity as potential diagnostic biomarkers. A random forest-based classifier composed of 25 lncRNA biomarkers (RF-25lncRNA) was developed for predicting osteoporosis risk. Performance evaluation with the leave-one-out cross-validation procedure showed that the RF-25lncRNA achieved well performance in distinguishing high and low BMD subjects in different osteoporosis datasets. Our study for the first time revealed a global view of lncRNA-associated ceRNA regulation in osteoporosis and provided novel lncRNAs with ceRNA activity as candidate epigenetic diagnostic biomarkers for early detection of osteoporosis risk.
机译:长期非编码RNA(LNCRNA)的改变表达已涉及开发和人类疾病。然而,LNCRNA的功能作用和调节机制是骨质疏松症的竞争内源性RNA(CERNAS),以及对骨质疏松症风险的潜在临床意义在很大程度上是未开发的。在这项研究中,我们对基于“Cerna假设”的失调的LNCRNA,MRNA和MIRNA的配对表达谱和调节关系进行了综合分析,并构建了与105的骨质疏松症相关的失去的miRNA介导的LNCRNA-mRNA Cerna网络(疑难组)组成节点(包括8个miRNA,24 mRNA和73 LNCRNA)和515个边缘。功能分析表明脱疑表涉及已知的骨质疏松症或骨代谢相关的生物进展和途径。然后我们对Cerna活动进行了73个LNCRNA的随机林的特征选择,并以Cerna活性确定了73个LNCRNA中的25个,作为潜在的诊断生物标志物。开发出由25个LNCRNA生物标志物(RF-25LNCRNA)组成的随机林的分类器,用于预测骨质疏松症风险。随着左右交叉验证程序的性能评估显示RF-25LNCRNA在区分不同骨质疏松数据集中的高和低BMD受试者中实现了良好的性能。我们首次研究揭示了骨质疏松症的LNCRNA相关的Cerna调节的全球性观点,并为Cerna活性提供了新的LNCRNA作为候选表观遗传诊断生物标志物,用于早期发现骨质疏松症风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号